C.A. Slabber et al. / Journal of Organometallic Chemistry 723 (2013) 122e128
127
4.8. 2-(2-Methylpropyl)-1,3,2-benzodiazaborole (3f)
8.19 ppm (s, 2H, 2x NH) 11B NMR (160 MHz, DMSO-d6)
28.7 ppm (s) 13C NMR (125 MHz, DMSO-d6)
55.5 ppm (q, 1C,
d
d
4.8.1. Method A
CH3) 105.9 ppm (d, 2C, 2x CHeCqeN) 113.7 ppm (d, 2C, 2x CHeCqe
O) 116.5 ppm (d, 2C, 2x CHeCqeCq) 119.9 ppm (s, 2C, 2x CqeN)
128.1 ppm (d, 2C, 2x CHeCHeCH) 134.8 ppm (d, 2C, 2x CHeCqe
B) 136.4 ppm (s, 1C, CHeCqeCq) 142.9 ppm (s, 1C, CqeCqeCq)
161.5 ppm (s, 1C, CqeOeCH3) 15N NMR (50 MHz, DMSO-d6)
313 mg, 90%.1H NMR (500 MHz, DMSO-d6)
d 0.96 ppm (d,
J ¼ 6.5 Hz, 6H, 2x CH3) 1.07 ppm (d, J ¼ 7.1 Hz, 2H, CHeCH2eB),1.91e
1.99 ppm (m, J ¼ 6.7 Hz, 1H, (CH3)2eCHeCH2) 6.70e6.73 ppm (m,
J¼ 5.6Hz, J¼ 3.2Hz,2H,CHeCHeCqeN)6.91e6.94ppm(m, J¼ 5.6Hz,
J ¼ 3.2 Hz, 2H, 2x CHeCHeCqeN) 8.33 ppm (s, 2H, 2x NH) 11B NMR
d
101 ppm; HRMS calcd for C17H14BN2O: 273.1199; found 273.1201.
(160 MHz, DMSO-d6)
d
31.7 ppm (s) 13C NMR (125 MHz, DMSO-d6)
d
23.0 ppm (t, 1C, CH2) 25.9 ppm (q, 2C, 2x CH3) 26.2 ppm (d, 1C,
4.11.2. Method D
CH) 110.6 ppm (d, 2C, 2x CHeCHeCqeN) 118.0 ppm (d, 2C, 2x CHe
103 mg, 95%.
CHeCqeN) 137.4 ppm (s, 2C, 2x CqeN) 15N NMR (50 MHz, DMSO-
d6)
d
113 ppm; HRMS calcd for C10H15BN2: 174.0516; found 174.0521.
4.12. 2-(4-Methylphenyl)-naphtho[1,8-de][1,3,2]diazaborine (5d)
[28]
4.8.2. Method B
49 mg, 70%.
4.12.1. Method C
411 mg, 80%.1H NMR (500 MHz, DMSO-d6)
d 2.35 ppm (s, 3H, CH3)
4.9. 2-Phenylenaphtho[1,8-de][1,3,2]diazaborine (5a) [17]
6.58 ppm (dd, J ¼ 7.4 Hz, J ¼ 0.85 Hz, 2H 2x CHeCqeN) 6.89 ppm
(dd,,J ¼ 8.2 Hz, J ¼ 0.90 Hz, 2H, 2xCHeCqeCq) 7.09 ppm (dd, J ¼ 7.8 Hz,
2H, 2x CHeCHeCH) 7.25 ppm (dd, J ¼ 8.0 Hz, J ¼ 0.60 Hz, 2H,2x CHe
CqeCH3) 7.82 ppm (d, J ¼ 7.9 Hz, 2H, 2x CHeCqeB) 8.19 ppm (s, 2H, 2x
4.9.1. Method C
413 mg, 85%. 1H NMR (500 MHz, DMSO-d6)
d 6.60 ppm (dd,
J ¼ 7.5 Hz, J ¼ 0.75 Hz, 2H, 2x CHeCqeN) 6.91 ppm (dd, J ¼ 8.3 Hz,
J ¼ 0.72 Hz, 2H,2x CHeCqeCq) 7.09 ppm (dd, J ¼ 7.8 Hz, 2H, 2x CHe
CHeCH) 7.42e7.48 ppm (m, 3H, CHeCHeCH) 7.92e7.94 ppm (m,
J ¼ 7.7 Hz, J ¼ 1.7 Hz, 2H, CHeCqeB) 8.24 ppm (s, 2H, 2x NH) 11B NMR
NH) 11B NMR (160 MHz, DMSO-d6) 29.2 ppm (s) 13C NMR (125 MHz,
d
DMSO-d6)
d 21.6 ppm (q, 1C, CH3) 106.0 ppm (d, 2C, 2x CHeCqeN)
116.6 ppm (d, 2C, 2x CHeCqeCq) 120.0 ppm (s, 2C, 2x CqeN)
128.1 ppm (d, 2C, 2x CHeCHeCH) 128.7 ppm (d, 2C, 2x CHeCqe
CH3) 133.2 ppm (d, 2C, 2x CHeCqeB) 136.4 ppm (s, 2C, 2x CHeCqe
Cq) 139.9 ppm (s,1C, CqeCH3) 142.9 ppm (s, 2C, 2x CqeCqeCq) 15N
(160 MHz, DMSO-d6) d
30.0 ppm (s) 13C NMR (125 MHz, DMSO-d6)
d
106.1 ppm (d, 2C, 2x CHeCqeN) 116.7 ppm (d, 2C, 2x CHeCqeCq)
120.1 ppm (s, 2C, 2x CqeN) 127.9 ppm (d, 4C, CHeCHeCH and 2x
CHeCHeCqeCq) 130.4 ppm (d, 1C, CHeCHeCH) 133.1 ppm (d, 2C, 2x
CHeCqeB) 136.4 ppm (s,1C, CHeCqeCq) 142.8 ppm (s,1C, CqeCqeCq)
NMR (50 MHz, DMSO-d6)
257.1250; found 257.1248.
d 101 ppm; HRMS calcd for C17H14BN2 :
15N NMR (50 MHz, DMSO-d6)
243.1094; found 243.1092.
d
101 ppm; HRMS calcd for C16H12BN2:
4.12.2. Method D
77 mg, 75%.
4.9.2. Method D
4.13. 2-[4-(Methylsulfanyl)phenyl]enaphtho[1,8-de][1,3,2]
diazaborine (5e) [19]
98 mg, 90%.
4.10. 2-(4-Chlorophenyl)enaphtho[1,8-de][1,3,2]diazaborine (5b)
[18]
4.13.1. Method C
441 mg, 76%. 1H NMR (500 MHz, DMSO-d6)
d 2.52 ppm (s, 3H,
SCH3) 6.58 ppm (dd, J ¼ 7.4 Hz, J ¼ 0.85 Hz, 2H, 2x CHeCqeN)
6.89 ppm (dd, J ¼ 8.1 Hz, J ¼ 0.82 Hz, 2H, 2x CHeCqeCq) 7.07 ppm
(m, J ¼ 7.7 Hz, 2H, 2x CHeCHeCH) 7.31 ppm (d, J ¼ 8.4 Hz, 2H, 2x CHe
CqeSCH3) 7.87 ppm (d, J ¼ 8.3 Hz, 2H, 2x CH-Cq-B) 8.22 ppm (s, 2H, 2x
4.10.1. Method C
415 mg, 75%. 1H NMR (500 MHz, DMSO-d6)
d 6.58 ppm (dd,
J ¼ 7.3 Hz, J ¼ 0.85 Hz, 2H, 2x CHeCqeN) 6.91 ppm (dd, J ¼ 8.3 Hz,
J ¼ 0.84 Hz, 2H, 2x CHeCqeCq) 7.08 ppm (dd, J ¼ 7.8 Hz, 2H, 2x CHe
CHeCH) 7.49e7.53 ppm (m, 2H, CHeCqeCH) 7.94e7.97 ppm (m,
2H, 2x CHeCqeB) 8.30 ppm (s, 2H, 2x NH) 11B NMR (160 MHz, DMSO-
NH) 11B NMR (160 MHz, DMSO-d6) 28.7 ppm (s) 13C NMR (125 MHz,
d
DMSO-d6) d 14.7 ppm (q, 1C, SCH3) 106.1 ppm (d, 2C, 2x CHeCqeN)
116.6 ppm (d, 2C, 2x CHeCqeCq) 120.1 ppm (s, 2C, 2x CqeN)
125.2 ppm (d, 2C, 2x CHeCqeSCH3) 128.1 ppm (d, 2C, 2x CHeCHe
CH) 133.6 ppm (d, 2C, 2x CHeCqeB) 136.4 ppm (s, 2C, 2x CHeCqe
Cq) 141.0 ppm (s, 1C, CqeS) 142.8 ppm (s, 2C, 2x CqeCqeCq) 15N
d6) d d 106.2 ppm (d, 2C,
28.8 ppm (s) 13C NMR (125 MHz, DMSO-d6)
2x CHeCqeN) 116.8 ppm (d, 2C, 2x CHeCqeCq) 120.2 ppm (s, 2C, 2x
CqeN) 128.1 ppm (d, 2x CHeCHeCH or CHeCqeCl) 128.2 ppm (d, 2x
CHeCHeCHorCHeCqeCl)135.0ppm(d,2C, 2xCHeCqeB)135.5ppm
(s, 1C, CHeCqeCl or CHeCqeCq) 136.4 ppm (s, 1C, CHeCqeCl or CHe
CqeCq) 142.3 ppm (s, 1C, CqeCqeCq) 15N NMR (50 MHz, DMSO-d6)
NMR (50 MHz, DMSO-d6)
290.1049; found 290.1050.
d 100 ppm HRMS calcd for C17H15BN2S:
d
101 ppm; HRMS calcd for C16H11BN2Cl: 277.0704; found 277.0701.
4.13.2. Method D
93 mg, 80%.
4.10.2. Method D
88 mg, 88%.
4.14. 2-(2-Methylpropyl)-naphtho[1,8-de][1,3,2]diazaborine (5f)
4.11. 2-(4-Methoxyphenyl)enaphtho[1,8-de][1,3,2]diazaborine (5c)
[28]
4.14.1. Method C
376 mg, 84%; 1H NMR (500 MHz, DMSO-d6)
d 0.77 ppm (d,
J ¼ 7.4 Hz, 2H, CH2eB) 0.95 ppm (d, 6.6 Hz, 6H, 2x CH3eCHeCH2) 1.9e
2.0 ppm (m, 1H, CH3eCHeCH2) 6.39 ppm (dd, J ¼ 7.5 Hz, J ¼ 0.95 Hz,
2H, 2xCHeCqeN)6.83ppm(dd,J¼8.4Hz,J¼ 0.83Hz, 2H, 2xCHeCqe
Cq) 7.02 ppm (m, J ¼ 7.8 Hz, 2H, 2x CHeCHeCH) 7.70 ppm (s, 2H, 2x
4.11.1. Method C
437 mg, 80%. 1H NMR (500 MHz, DMSO-d6)
d 3.81 ppm (s, 3H,
CH3) 6.58 ppm (dd, J ¼ 7.4 Hz, J ¼ 0.95 Hz, 2H, 2x CHeCqeN)
6.88 ppm (dd, J ¼ 8.2 Hz, J ¼ 0.76 Hz, 2H, 2x CHeCqeCq)
7.00 ppm (d, J ¼ 8.7 Hz, 2H, 2x CHeCqeO) 7.07 ppm (t, J ¼ 8.0 Hz,
2H, 2x CHeCHeCH) 7.89 ppm (d, J ¼ 8.7 Hz, 2H, 2x CHeCqeB)
NH) 11B NMR (160 MHz, DMSO-d6) 32.6 ppm (s) 13C NMR (125 MHz,
d
DMSO-d6)
d 24.8 ppm (d,1C, CH3eCHeCH2) 25.4 ppm (q, 2C, 2xCH3e
CHeCH2) 25.8 ppm (t, 1C, CH2eB) 104.9 ppm (d, 2C, 2x CHeCqeN)